AVITA Medical (AVHHL) Cash & Current Investments (2018 - 2025)

AVITA Medical has reported Cash & Current Investments for 8 years, with the latest figure at $18.2 million in Q4 2025.

• For the quarter ending Q4 2025, Cash & Current Investments fell 49.32% year-over-year to $18.2 million; the trailing twelve-month figure through Dec 2025 stood at $18.2 million (down 49.32% YoY), and the FY2025 full-year result was $18.2 million, down 49.32% from the prior year.
• Cash & Current Investments for Q4 2025 stood at $18.2 million, up from $16.2 million in the prior quarter.
• The five-year high for Cash & Current Investments was $115.1 million in Q1 2021, with the low at $14.1 million in Q2 2025.
• Historically, Cash & Current Investments has averaged $63.0 million across 5 years, with a median of $69.2 million in 2023.
• Annual changes were most pronounced in 2021 — Cash & Current Investments soared 50.25% — and 2025, when it plunged 73.96%.
• AVITA Medical's Cash & Current Investments stood at $85.4 million in 2021, then fell by 7.05% to $79.3 million in 2022, then decreased by 1.26% to $78.3 million in 2023, then sank by 54.19% to $35.9 million in 2024, then tumbled by 49.32% to $18.2 million in 2025.
• The last three Cash & Current Investments figures came in at $18.2 million (Q4 2025), $16.2 million (Q3 2025), and $14.1 million (Q2 2025), per Business Quant data.